Biohaven Cash on Hand 2016-2022 | BHVN
Biohaven cash on hand from 2016 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Biohaven Annual Cash on Hand
(Millions of US $) |
| 2021 |
$365 |
| 2020 |
$355 |
| 2019 |
$317 |
| 2018 |
$264 |
| 2017 |
$131 |
| 2016 |
$24 |
| 2015 |
$1 |
Biohaven Quarterly Cash on Hand
(Millions of US $) |
| 2022-09-30 |
$51 |
| 2022-06-30 |
$553 |
| 2022-03-31 |
$602 |
| 2021-12-31 |
$76 |
| 2021-09-30 |
$520 |
| 2021-06-30 |
$366 |
| 2021-03-31 |
$566 |
| 2020-12-31 |
$355 |
| 2020-09-30 |
$546 |
| 2020-06-30 |
$261 |
| 2020-03-31 |
$428 |
| 2019-12-31 |
|
| 2019-09-30 |
$417 |
| 2019-06-30 |
$466 |
| 2019-03-31 |
$217 |
| 2018-12-31 |
$264 |
| 2018-09-30 |
$168 |
| 2018-06-30 |
$217 |
| 2018-03-31 |
$104 |
| 2017-12-31 |
$131 |
| 2017-09-30 |
$176 |
| 2017-06-30 |
$204 |
| 2017-03-31 |
$52 |
| 2016-12-31 |
$24 |
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.240B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
